In addition, the NTN‐1/DCC signaling pathway needs to be tested in models other than MPTP neurotoxin to confirm whether it contributes to neurodegeneration in PD and whether targeting this signaling pathway can alleviate or even reverse the damage of DA neurons. This evidence concerns the gene DCC and Parkinson disease.